Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

New study shows how regular exercise protects against fatty liver disease

Exercise not only trains the muscles but can also prevent the development of fatty liver. A new study by the German Center for Diabetes Research, Helmholtz Munich and Tübingen University Hospital shows which molecular adaptations, in particular of the liver mitochondria, can be observed in this process.

20 Dec 2021

Physicians who rely only on liver function test can fail to diagnose alcoholic cirrhosis

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver function test to diagnose alcoholic cirrhosis.

20 Dec 2021

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

Expanding Medicaid may reduce fatalities, study says

In 2010, the newly passed Affordable Care Act – also known as Obamacare – mandated that states expand Medicaid eligibility to cover millions of uninsured Americans.

3 Dec 2021

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

A UC Davis Health team has developed a first-of-its-kind positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease.

30 Nov 2021

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Some of the UK's leading health charities including the British Heart Foundation, Diabetes UK and Cancer Research UK are joining forces with the government and the NHS to encourage vulnerable people to get their COVID-19 vaccines.

25 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Hepatologists experience workplace discrimination, survey finds

Hepatologists -- physicians who specialize in liver disease -- say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).

22 Nov 2021

New score developed to predict outcome in liver cancer patients receiving immunotherapy

There are still no established biomarkers to predict the success of immunotherapy in patients with liver cancer.

22 Nov 2021

Monitoring cellular metabolism for NAFLD/NASH liver disease research

In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.

From Promega Corporation 22 Nov 2021

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Researchers recently used bioinformatics analysis techniques to explore the diseases caused by SARS-CoV-2 infection in the human digestive tract.

22 Nov 2021

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease

A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment.

17 Nov 2021

COVID-19 booster shot extremely beneficial for most cancer patients

Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center.

16 Nov 2021

Could drugs derived from microalgae be effective against COVID-19?

Researchers discuss the ability of some microalgae metabolites to prevent cytokine storm syndrome during COVID-19.

15 Nov 2021

Bariatric surgery lowers risk of liver disease, heart complications in patients with fatty liver disease

A Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric weight loss surgery significantly lowered their future risk of liver disease complications and serious cardiovascular disease compared with patients who did not have surgery.

11 Nov 2021

Protein in the blood could predict type 2 diabetes many years before diagnosis

A large study led by Lund University in Sweden has identified a protein in the blood that could predict type 2 diabetes up to nineteen years before the onset of the disease.

11 Nov 2021

Researchers uncover new genetic link to non-alcoholic steatohepatitis

Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.

10 Nov 2021

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.

9 Nov 2021

Liver Disease News and Research

Further Reading

New study shows how regular exercise protects against fatty liver disease

Physicians who rely only on liver function test can fail to diagnose alcoholic cirrhosis

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Expanding Medicaid may reduce fatalities, study says

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Hepatologists experience workplace discrimination, survey finds

New score developed to predict outcome in liver cancer patients receiving immunotherapy

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Success of covid antiviral pills hinges on access to speedy and accurate tests

Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease

COVID-19 booster shot extremely beneficial for most cancer patients

Could drugs derived from microalgae be effective against COVID-19?

Bariatric surgery lowers risk of liver disease, heart complications in patients with fatty liver disease

Protein in the blood could predict type 2 diabetes many years before diagnosis

Researchers uncover new genetic link to non-alcoholic steatohepatitis

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News